Session (CTI)

Purpose: Despite sharing a similar goal to use resources efficiently to maximize returns for patients and society, health economics and health investment have historically operated as two different sectors. As the scrutiny over market-based mechanisms for drug pricing intensifies and as we enter one of the largest patent cliffs on record, the need for coordination of health economic expertise and health investment expertise is obvious. This workshop will share real-world case studies and lessons learned from integrating health economic approaches within health investment strategy. Participants will learn how health economic approaches can be integrated into healthcare investment strategies and how health economic studies can better reflect real-world investment decisions. Description: The workshop will be moderated by Dr. Whittington who will summarize the different objectives of health economics and health investment (5 mins). Dr. Li, health economist at an investment bank, will provide examples of how she has incorporated a health economic lens into equity research (5 mins). Dr. Xie, a health economist at a multi-stage investment management company, will describe using generalized cost-effectiveness analysis to communicate the societal value for a portfolio company prior to their acquisition (5 mins). Dr. VanSickle, a health economist at a healthcare investment firm, will explain how health economic principles are considered as part of due diligence and investment strategy (5 mins). Panelists will then participate in a fireside chat (20 mins) to discuss 1) the impacts of their efforts, 2) adaptations to health economic methods to align with investor strategy, 3) how and when the need for a health economic lens arises, 4) and opportunities for the future. The fireside chat will conclude with audience polling to assess the feasibility of the adaptations to health economic methods to align with investor strategy. Twenty minutes will be reserved for audience Q&A.